These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute leukemia after infliximab therapy. Alcaín G, Andrade RJ, Queipo de Llano MP, Moreno MJ, García-Cortés M, Franquelo E. Am J Gastroenterol; 2003 Nov; 98(11):2577. PubMed ID: 14638375 [No Abstract] [Full Text] [Related]
3. Severe adenovirus pneumonia (AVP) following infliximab infusion for the treatment of Crohn's disease. Ahmad NM, Ahmad KM, Younus F. J Infect; 2007 Jan; 54(1):e29-32. PubMed ID: 16678268 [Abstract] [Full Text] [Related]
5. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab]. Bermejo F, López San Román A, Algaba A, van Domselaar M, Carneros JA, Rivero M, Piqueras B, Valer MP. Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078 [Abstract] [Full Text] [Related]
9. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha. Conti F, Ceccarelli F, Priori R, Iagnocco A, Signore A, Valesini G. Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158 [No Abstract] [Full Text] [Related]
15. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration. Toki H, Momohara S, Tsukahara S, Ikari K. J Rheumatol; 2008 Sep 15; 35(9):1896-7; author reply 1897. PubMed ID: 18785300 [No Abstract] [Full Text] [Related]
16. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease. Clare DF, Alexander FC, Mike S, Dan G, Allan F, Lisa W, Peter HJ. Eur J Gastroenterol Hepatol; 2009 Jan 15; 21(1):71-5. PubMed ID: 19060632 [Abstract] [Full Text] [Related]
17. Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction. Kugathasan S, Levy MB, Saeian K, Vasilopoulos S, Kim JP, Prajapati D, Emmons J, Martinez A, Kelly KJ, Binion DG. Am J Gastroenterol; 2002 Jun 15; 97(6):1408-14. PubMed ID: 12094858 [Abstract] [Full Text] [Related]
18. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding]. MMW Fortschr Med; 2008 Dec 11; 150(51-52):54-5. PubMed ID: 19156959 [No Abstract] [Full Text] [Related]
19. Infliximab-induced acne: report of two cases. Bassi E, Poli F, Charachon A, Claudepierre P, Revuz J. Br J Dermatol; 2007 Feb 11; 156(2):402-3. PubMed ID: 17223901 [No Abstract] [Full Text] [Related]
20. Favorable response to high-dose infliximab for refractory childhood uveitis. Kahn P, Weiss M, Imundo LF, Levy DM. Ophthalmology; 2006 May 11; 113(5):860-4.e2. PubMed ID: 16545455 [Abstract] [Full Text] [Related] Page: [Next] [New Search]